O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+6.96%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.91B
AUM Growth
+$7.91B
(+12%)
Cap. Flow
+$959M
Cap. Flow
% of AUM
12.12%
Top 10 Holdings %
Top 10 Hldgs %
33.78%
Holding
159
New
26
Increased
22
Reduced
25
Closed
17
Top Buys
| 1 |
Prelude Therapeutics
PRLD
|
$470M |
| 2 |
PMV Pharmaceuticals
PMVP
|
$260M |
| 3 |
AFIB
Acutus Medical, Inc. Common Stock
AFIB
|
$163M |
| 4 |
CalciMedica
CALC
|
$56.9M |
| 5 |
Theravance Biopharma
TBPH
|
$54.2M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$128M |
| 2 |
Cigna
CI
|
$82.5M |
| 3 |
Natera
NTRA
|
$81.6M |
| 4 |
Glaukos
GKOS
|
$46.5M |
| 5 |
Alector
ALEC
|
$34.2M |
Sector Composition
| 1 | Healthcare | 98.49% |
| 2 | Financials | 0.64% |
| 3 | Technology | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Stryker
SYK
$150B
| $49M | 0.62% | +235,000 | New | +$49M |
|
52
Thermo Fisher Scientific
TMO
$186B
| $48.7M | 0.61% | 110,300 | – | – |
|
|
ATNX
53
DELISTED
Athenex, Inc. Common Stock
ATNX
| $48.1M | 0.61% | 3,977,950 -31,396 | -0.8% | -$380K |
|
54
Adverum Biotechnologies
ADVM
$64.6M
| $47.2M | 0.59% | 4,584,344 +1,293,600 | +39% | +$13.3M |
|
|
CHNG
55
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $44.9M | 0.56% | +3,093,700 | New | +$44.9M |
|
56
Crinetics Pharmaceuticals
CRNX
$2.92B
| $43.1M | 0.54% | 2,753,567 | – | – |
|
57
KALA BIO
KALA
$78.8M
| $41M | 0.52% | 5,465,030 +62,300 | +1% | +$467K |
|
58
AbbVie
ABBV
$372B
| $40.6M | 0.51% | 464,000 | – | – |
|
|
FUSN
59
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $38.8M | 0.49% | 3,224,770 | – | – |
|
60
scPharmaceuticals
SCPH
$295M
| $35.7M | 0.45% | 4,797,148 | – | – |
|
61
uniQure
QURE
$896M
| $35.7M | 0.45% | 969,079 | – | – |
|
|
VRNA
62
Verona Pharma
VRNA
$9.16B
| $35.5M | 0.45% | 5,694,841 +4,444,445 | +355% | +$27.7M |
|
63
Prothena Corp
PRTA
$441M
| $35.4M | 0.45% | 3,544,475 | – | – |
|
64
Acadia Healthcare
ACHC
$2.12B
| $32.9M | 0.41% | 1,114,466 -265,694 | -19% | -$7.83M |
|
65
SI-BONE Inc
SIBN
$719M
| $32.5M | 0.41% | 1,368,500 -12,800 | -0.9% | -$304K |
|
|
ALPN
66
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $32.3M | 0.41% | 3,670,955 | – | – |
|
67
Applied Therapeutics
APLT
$71M
| $32.1M | 0.4% | 1,546,687 +329,009 | +27% | +$6.83M |
|
68
Vaxcyte
PCVX
$4B
| $31.6M | 0.4% | 640,760 -209,240 | -25% | -$10.3M |
|
|
HARP
69
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $31.2M | 0.39% | 1,835,704 | – | – |
|
|
70
Alector
ALEC
$238M
| $28.7M | 0.36% | 2,725,313 -3,250,009 | -54% | -$34.2M |
|
|
IMAB
71
I-MAB
IMAB
$340M
| $28.5M | 0.36% | +606,070 | New | +$28.5M |
|
72
Spyre Therapeutics
SYRE
$996M
| $28.5M | 0.36% | 4,015,524 | – | – |
|
73
Xenon Pharmaceuticals
XENE
$2.98B
| $27.7M | 0.35% | 2,497,917 | – | – |
|
|
SVA
74
DELISTED
Sinovac Biotech, Ltd
SVA
| $27.3M | 0.34% | 2,839,500 | – | – |
|
75
Corvus Pharmaceuticals
CRVS
$428M
| $27.1M | 0.34% | 6,767,584 | – | – |
|